Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebif clone 484-39 immunogenicity and safety study in relapsing-remitting multiple sclerosis
2004-000337-12Phase 4Completed
- Sponsor
- Serono
- Start
- Sep 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Serono. Primary endpoint: Proportion of subjects developing neutralizing antibodies at week 48. Started Sep 2004; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-000337-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000337-12.